Table 1.
Clinical features and Pit Ab prevalence of the study population at the time of serum collection
| Disease | No. (F, M) | Age (mean ± sd) | Pituitary surgery | Adenoma size 10 mm or greater | Positive for pituitary antibodies by IF |
|---|---|---|---|---|---|
| ACTH-secreting adenoma | 29 (24, 5) | 44 ± 11 | 29 | 10 | 2 (7%) |
| GH-secreting adenoma | 68 (39, 29) | 53 ± 13 | 52 | 44 | 3 (4%) |
| PRL-secreting adenoma | 71 (54, 17) | 39 ± 14 | 14 | 26 | 6 (8%) |
| TSH-secreting adenoma | 13 (6, 7) | 51 ± 15 | 10 | 2 | 0 |
| Non-secreting adenoma | 110 (74, 36) | 51 ± 19 | 66 | 80 | 4 (4%) |
| Healthy controls | 409 (312, 97) | 45 ± 15 | 0 | NA | 3 (1%) |
| Hypophysitis controls | 14 (11, 3) | 35 ± 12 | 14 | NA | 8 (57%) |
IF, Immunofluorescence assay; NA, not applicable.